Stopping Lamictal (lamotrigine) abruptly can trigger increased seizure activity, mood episode relapse, and a range of withdrawal symptoms including headaches, fatigue, and moodiness. The FDA recommends tapering the dose over at least two weeks, cutting it by roughly 50% each week, rather than stopping cold turkey. What happens specifically depends on why you’re taking it and how quickly you stop.
Seizure Risk Increases Quickly
If you take Lamictal for epilepsy, stopping suddenly is the most dangerous scenario. Research on rapid withdrawal found that seizure duration and frequency both increased significantly during the tapering process, and all patients in the study experienced more severe seizures during withdrawal. The seizures didn’t just come back at their previous level; they got worse, with longer and more intense episodes than what patients had before starting the medication.
The FDA label states this directly: in clinical trials for bipolar disorder, two patients experienced seizures shortly after abrupt withdrawal, even though seizure control wasn’t the reason they were taking the drug. This means stopping suddenly carries seizure risk even if you’ve never had epilepsy.
Bipolar Relapse Rates After Stopping
For people taking Lamictal to manage bipolar disorder, discontinuation significantly raises the chance of a mood episode returning. A meta-analysis of randomized controlled trials found that stopping bipolar medications for six months nearly doubled the risk of any mood episode compared to staying on them. Manic and hypomanic episodes were hit hardest, with the risk more than doubling after discontinuation.
That said, the picture isn’t all-or-nothing. About 47% of people who stopped their medication for six months did not experience a recurrence. So relapse is far from guaranteed, but the odds shift meaningfully against you once you’re off the drug for more than a month. The risk was elevated at every time point researchers measured, from one month out to two years.
Withdrawal Symptoms to Expect
Lamictal has a half-life of about 29 hours, meaning it takes roughly six days for the drug to clear your system after your last dose. During that window and sometimes beyond it, people report a cluster of withdrawal effects:
- Fatigue and lethargy that can feel like a heavy fog
- Headaches
- Moodiness and irritability, sometimes tipping into hostility
- Difficulty concentrating
- Body tingling and other unusual sensory sensations
- Worsening mental health symptoms, including, in some cases, suicidal thoughts
These aren’t universally experienced, and they tend to be more pronounced with abrupt stops than with gradual tapers. The FDA specifically warns that abruptly stopping Lamictal can result in new or worsening mental health symptoms, which is one reason the taper schedule exists.
How a Safe Taper Works
The FDA-recommended approach is straightforward: reduce your dose by about 50% per week over a minimum of two weeks. So if you’re on 200 mg, you’d drop to 100 mg for a week, then to 50 mg for a week, then stop. Your prescriber may stretch this out longer depending on your dose, how long you’ve been on the medication, and how sensitive you are to changes.
The only exception is when a safety concern, most notably a serious rash, demands immediate discontinuation. In that case the risk of continuing outweighs the risk of stopping abruptly.
Restarting After a Break
If you stop Lamictal for more than a few days and want to restart, you generally can’t just jump back to your previous dose. The medication needs to be re-titrated slowly from the beginning, following the same gradual dose increases used when you first started. This matters because of the risk of Stevens-Johnson syndrome (SJS), a rare but serious skin reaction that’s most likely to occur during the initial weeks of treatment or when doses increase too quickly.
Restarting within four weeks of a previous rash reaction increases the chance of the rash recurring from about 4% to 37%. For people who experienced only a mild rash without systemic symptoms like fever, sore throat, or flu-like illness, reintroduction may be safe under medical supervision. But if the original rash came with those systemic signs, or if it was diagnosed as SJS, the drug generally should not be tried again.
Stopping During Pregnancy
Some people consider stopping Lamictal when they become pregnant, worried about effects on the baby. Research following newborns exposed to lamotrigine throughout pregnancy found no major malformations, no significant withdrawal symptoms in the newborns, and no difference in neurodevelopmental outcomes up to age 12. Lamotrigine is considered one of the safer anti-seizure medications during pregnancy, and stopping it carries its own risks: uncontrolled seizures during pregnancy pose serious dangers to both mother and baby. The decision involves weighing those competing risks rather than defaulting to discontinuation.